BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 24372552)

  • 1. Detection of QTc interval prolongation using jacket telemetry in conscious non-human primates: comparison with implanted telemetry.
    Derakhchan K; Chui RW; Stevens D; Gu W; Vargas HM
    Br J Pharmacol; 2014 Jan; 171(2):509-22. PubMed ID: 24372552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measuring the risk of torsades de pointes: electrocardiographic evaluation of PNU-142093 in conscious cynomolgus non-human primates using restraint and non-restraint procedures.
    Bass AS; Hanson LA; Jackson TA
    J Pharmacol Toxicol Methods; 2009; 60(1):51-7. PubMed ID: 19447184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose-response effects of sotalol on cardiovascular function in conscious, freely moving cynomolgus monkeys.
    Lynch JJ; Wilson AW; Hernandez LE; Nelson RA; Marsh KC; Cox BF; Mittelstadt SW
    Br J Pharmacol; 2008 Aug; 154(7):1439-45. PubMed ID: 18516073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of group housing on ECG assessment in conscious cynomolgus monkeys.
    Xing G; Lu J; Hu M; Wang S; Zhao L; Zheng W; Schofield J; Oldman K; Adkins D; Yu H; Platz S; Ren J; Skinner M
    J Pharmacol Toxicol Methods; 2015; 75():44-51. PubMed ID: 25979821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term stability, reproducibility, and statistical sensitivity of a telemetry-instrumented dog model: A 27-month longitudinal assessment.
    Fryer RM; Ng KJ; Chi L; Jin X; Reinhart GA
    J Pharmacol Toxicol Methods; 2015; 74():26-32. PubMed ID: 25946685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive telemetric electrocardiogram assessment in conscious beagle dogs.
    Prior H; McMahon N; Schofield J; Valentin JP
    J Pharmacol Toxicol Methods; 2009; 60(2):167-73. PubMed ID: 19539041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of two external telemetry systems (PhysioJacket and JET) in beagle dogs with telemetry implants.
    Chui RW; Fosdick A; Conner R; Jiang J; Bruenner BA; Vargas HM
    J Pharmacol Toxicol Methods; 2009; 60(1):58-68. PubMed ID: 19426820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous solid tip ECG lead placement in telemetry implanted dogs: Part 2: High quality telemetry signals yield high sensitivity to drug-induced changes.
    Mitchell AZ; Bills AJ; Wittwer GT; Foley CM; Kremer JJ; Chen H; Osinski MA
    J Pharmacol Toxicol Methods; 2013; 68(1):62-73. PubMed ID: 23639348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of drug-induced QT prolongation in a halothane-anesthetized monkey model: effects of sotalol.
    Ishizaka T; Yoshimatsu Y; Ozawa M; Kimotsuki T; Takasaki W; Manabe S; Yasuda M
    J Pharmacol Toxicol Methods; 2009; 59(2):86-93. PubMed ID: 19367688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation and utility of the PhysioTel™ Digital M11 telemetry implant for cardiovascular data evaluation in cynomolgus monkeys and Beagle dogs.
    Cordes JS; Heyen JR; Volberg ML; Poy N; Kreuser S; Shoieb AM; Steidl-Nichols J
    J Pharmacol Toxicol Methods; 2016; 79():72-9. PubMed ID: 26844408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are women more susceptible than men to drug-induced QT prolongation? Concentration-QTc modelling in a phase 1 study with oral rac-sotalol.
    Darpo B; Karnad DR; Badilini F; Florian J; Garnett CE; Kothari S; Panicker GK; Sarapa N
    Br J Clin Pharmacol; 2014 Mar; 77(3):522-31. PubMed ID: 23819796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting drug-induced changes in ECG parameters using jacketed telemetry: Effect of different data reduction techniques.
    Skinner M; Xing G; Lu J; Ren J; Oldman K
    J Pharmacol Toxicol Methods; 2017; 85():38-48. PubMed ID: 28065822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of a probabilistic method for the determination of drug-induced QT prolongation in telemetered cynomolgus monkeys: effects of moxifloxacin.
    Holzgrefe HH; Cavero I; Buchanan LV; Gill MW; Durham SK
    J Pharmacol Toxicol Methods; 2007; 55(3):227-37. PubMed ID: 17097307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A method for QT correction based on beat-to-beat analysis of the QT/RR interval relationship in conscious telemetred beagle dogs.
    Batey AJ; Doe CP
    J Pharmacol Toxicol Methods; 2002; 48(1):11-9. PubMed ID: 12750037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular monkey telemetry: sensitivity to detect QT interval prolongation.
    Chaves AA; Keller WJ; O'Sullivan S; Williams MA; Fitzgerald LE; McPherson HE; Goykhman D; Ward PD; Hoe CM; Mixson L; Briscoe RJ
    J Pharmacol Toxicol Methods; 2006; 54(2):150-8. PubMed ID: 16679034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calculation of QT shift in non clinical safety pharmacology studies.
    Champeroux P; Martel E; Fowler JS; Maurin A; Sola ML; Jude S; Elamrani F; Weyn AA; Laveissiere A; Lala P; Richard S
    J Pharmacol Toxicol Methods; 2009; 59(2):73-85. PubMed ID: 19135537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rate dependence of sotalol-induced prolongation of ventricular repolarization during exercise in humans.
    Funck-Brentano C; Kibleur Y; Le Coz F; Poirier JM; Mallet A; Jaillon P
    Circulation; 1991 Feb; 83(2):536-45. PubMed ID: 1846784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reference intervals and method sensitivity for electrocardiology, hemodynamics, and body temperature parameters in healthy cynomolgus monkeys.
    Fang X; Tichenor SD
    J Pharmacol Toxicol Methods; 2023; 120():107247. PubMed ID: 36581147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measurements of blood pressure and electrocardiogram in conscious freely moving guineapigs: a model for screening QT interval prolongation effects.
    Hess P; Rey M; Wanner D; Steiner B; Clozel M
    Lab Anim; 2007 Oct; 41(4):470-80. PubMed ID: 17988441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anesthetized guinea pig: an effective early cardiovascular derisking and lead optimization model.
    Morissette P; Nishida M; Trepakova E; Imredy J; Lagrutta A; Chaves A; Hoagland K; Hoe CM; Zrada MM; Travis JJ; Zingaro GJ; Gerenser P; Friedrichs G; Salata JJ
    J Pharmacol Toxicol Methods; 2013; 68(1):137-49. PubMed ID: 23649000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.